VEGFR Inhibitors

VEGFR1/Flt-1

VEGFR2/KDR/Flk-1

VEGFR3/Flt-4

VEGFR Inhibitors

Product Name	VEGFR1/Flt-1	VEGFR2/KDR/Flk-1	VEGFR3/Flt-4	Purity
Sorafenib		VEGFR2, IC₅₀: 90 nM	VEGFR3, IC₅₀: 20 nM	99.92%
Lenvatinib	VEGFR1, IC₅₀: 22 nM	VEGFR2, IC₅₀: 4 nM	VEGFR3, IC₅₀: 5.2 nM	99.75%
Regorafenib	VEGFR1, IC₅₀: 13 nM	VEGFR2, IC₅₀: 4.2 nM	VEGFR3, IC₅₀: 46 nM	99.93%
Sunitinib		VEGFR2, IC₅₀: 80 nM		98.96%
Semaxinib		Flk-1, IC₅₀: 1.23 μM		99.96%
Nintedanib	VEGFR1, IC₅₀: 34 nM	VEGFR2, IC₅₀: 13 nM	VEGFR3, IC₅₀: 13 nM	99.94%
Cabozantinib	Flt-1, IC₅₀: 12 nM	VEGFR2, IC₅₀: 0.035 nM	Flt-4, IC₅₀: 6 nM	99.96%
Ponatinib		VEGFR2, IC₅₀: 1.5 nM		99.43%
Axitinib	VEGFR1, IC₅₀: 0.1 nM	VEGFR2, IC₅₀: 0.2 nM	VEGFR3, IC₅₀: 0.1 nM	99.94%
Pazopanib	VEGFR1, IC₅₀: 10 nM	VEGFR2, IC₅₀: 30 nM	VEGFR3, IC₅₀: 47 nM	99.91%
PD173074		VEGFR2, IC₅₀: 100 nM		99.70%
Fruquintinib	VEGFR1, IC₅₀: 33 nM	VEGFR2, IC₅₀: 35 nM	VEGFR3, IC₅₀: 0.5 nM	99.87%
Sorafenib Tosylate		VEGFR2, IC₅₀: 90 nM	VEGFR3, IC₅₀: 20 nM	99.91%
SU 5402		VEGFR2, IC₅₀: 20 nM		99.86%
Nintedanib esylate	VEGFR1, IC₅₀: 34 nM	VEGFR2, IC₅₀: 13 nM	VEGFR3, IC₅₀: 13 nM	99.95%
Vandetanib		VEGFR2, IC₅₀: 40 nM	VEGFR3, IC₅₀: 110 nM	99.95%
5Z-7-Oxozeaenol		VEGFR-2, IC₅₀: 52 nM	VEGFR-3, IC₅₀: 110 nM	99.60%
Tivozanib	VEGFR1, IC₅₀: 30 nM	VEGFR2, IC₅₀: 6.5 nM	VEGFR3, IC₅₀: 15 nM	99.37%
Lenvatinib mesylate	VEGFR1, IC₅₀: 22 nM	VEGFR2, IC₅₀: 4 nM	VEGFR3, IC₅₀: 5.2 nM	99.86%
Sunitinib Malate		VEGFR2, IC₅₀: 80 nM		99.91%
Foretinib		KDR, IC₅₀: 0.9 nM		99.77%
GW806742X		VEGFR2, IC₅₀: 2 nM		99.91%
Linifanib	Flt-1, IC₅₀: 3 nM	KDR, IC₅₀: 4 nM		99.28%
Sitravatinib	VEGFR1, IC₅₀: 6 nM	VEGFR2, IC₅₀: 5 nM	VEGFR3, IC₅₀: 2 nM	99.57%
Dovitinib	VEGFR1, IC₅₀: 10 nM	VEGFR2, IC₅₀: 13 nM	VEGFR3, IC₅₀: 8 nM	99.88%
MAZ51			VEGFR3	99.96%
Cediranib	Flt-1, IC₅₀: 5 nM	KDR, IC₅₀: 1 nM	Flt-4, IC₅₀: 3 nM	99.58%
(Z)-Guggulsterone		VEGF-R2		99.30%
Pazopanib Hydrochloride	VEGFR1, IC₅₀: 10 nM	VEGFR2, IC₅₀: 30 nM	VEGFR3, IC₅₀: 47 nM	99.99%
SAR131675			VEGFR3, IC₅₀: 23 nM	99.76%
Sulfatinib	VEGFR1	VEGFR2	VEGFR3	98.65%
Thymoquinone		VEGFR2		99.59%
PF-03814735	Flt-1, IC₅₀: 10 nM			99.58%
Ponatinib hydrochloride		VEGFR2, IC₅₀: 1.5 nM		99.55%
Zanzalintinib		VEGFR2, IC₅₀: 1.6 nM		99.73%
Regorafenib monohydrate	VEGFR1, IC₅₀: 13 nM	VEGFR2, IC₅₀: 4.2 nM	VEGFR3, IC₅₀: 46 nM	99.96%
Cabozantinib S-malate		VEGFR2, IC₅₀: 0.035 nM		99.90%
Regorafenib Hydrochloride	VEGFR1, IC₅₀: 13 nM	VEGFR2, IC₅₀: 4.2 nM	VEGFR3, IC₅₀: 46 nM	99.58%
Gandotinib		KDR, IC₅₀: 109 nM	Flt-4, IC₅₀: 25 nM	99.82%
PF 477736		VEGFR2, Ki: 8 nM		99.21%
Altiratinib		VEGFR2, IC₅₀: 9.2 nM		98.05%
Brivanib		VEGFR2, IC₅₀: 25 nM		99.92%
Tesevatinib		KDR, IC₅₀: 1.5 nM	Flt-4, IC₅₀: 8.7 nM	99.21%
RAF265		VEGFR2		99.80%
Lucitanib	VEGFR1, IC₅₀: 7 nM	VEGFR2, IC₅₀: 25 nM	VEGFR3, IC₅₀: 10 nM	98.94%
SU14813	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 50 nM		99.63%
Orantinib	Flt-1, Ki: 2.1 μM			99.21%
GW806742X hydrochloride		VEGFR2, IC₅₀: 2 nM		98.77%
Golvatinib		VEGFR2, IC₅₀: 16 nM		99.89%
Ilorasertib hydrochloride	VEGFR1, IC₅₀: 1 nM	VEGFR2, IC₅₀: 2 nM	VEGFR3, IC₅₀: 43 nM	98.48%
PP121		VEGFR2, IC₅₀: 12 nM		98.67%
ENMD-2076		KDR, IC₅₀: 58.2 nM	Flt-4, IC₅₀: 15.9 nM	99.12%
ODM-203	VEGFR1, IC₅₀: 26 nM	VEGFR2, IC₅₀: 9 nM	VEGFR3, IC₅₀: 5 nM	99.91%
Vatalanib dihydrochloride		VEGFR2, IC₅₀: 37 nM		99.91%
Motesanib	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 3 nM	VEGFR3, IC₅₀: 6 nM	99.96%
Ki8751		VEGFR2, IC₅₀: 0.9 nM		98.15%
Telatinib		VEGFR2, IC₅₀: 6 nM	VEGFR3, IC₅₀: 4 nM	99.60%
Cediranib maleate	Flt-1, IC₅₀: 5 nM	KDR, IC₅₀: 1 nM	Flt-4, IC₅₀: 3 nM	99.95%
BFH772		VEGFR2, IC₅₀: 3 nM
Toceranib		Flk-1, Ki: 6 nM
Famitinib		VEGFR-2, IC₅₀: 4.2 nM		98.43%
Ningetinib		VEGFR2, IC₅₀: 1.9 nM		99.82%
SCR-1481B1	VEGFR1			99.82%
OSI-930	Flt-1, IC₅₀: 8 nM	KDR, IC₅₀: 9 nM		98.57%
SU1498		Flk-1, IC₅₀: 700 nM		98.01%
TAK-593	VEGFR1, IC₅₀: 3.2 nM	VEGFR2, IC₅₀: 0.95 nM	VEGFR3, IC₅₀: 1.1 nM	99.66%
Brivanib (alaninate)		VEGFR2, IC₅₀: 25 nM		99.45%
Chiauranib	Flt-1, IC₅₀: 8 nM	KDR, IC₅₀: 7 nM	Flt-4, IC₅₀: 9 nM	99.28%
CP-547632		VEGFR-2, IC₅₀: 11 nM		99.16%
Tivozanib hydrochloride hydrate	VEGFR-1, IC₅₀: 30 nM	VEGFR-2, IC₅₀: 6.5 nM	VEGFR-3, IC₅₀: 15 nM	99.77%
K00546		VEGF-R2, IC₅₀: 32 nM		98.08%
BMS-794833		VEGFR2, IC₅₀: 15 nM		99.79%
Toceranib phosphate		Flk-1, Ki: 6 nM		98.54%
CP-547632 hydrochloride		VEGFR-2, IC₅₀: 11 nM		99.88%
MGCD-265 analog		VEGFR2, IC₅₀: 10 nM		98.47%
TG 100572 Hydrochloride	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 7 nM		98.96%
SU14813 maleate	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 50 nM		99.04%
Isolinderalactone		VEGFR2		98.79%
VEGFR-IN-1	Flt-1, IC₅₀: 0.18 μM	KDR, IC₅₀: 0.02 μM		98.42%
SU5408		VEGFR2, IC₅₀: 70 nM		≥98.0%
ZM323881 hydrochloride		VEGFR2, IC₅₀: 2 nM		99.63%
VEGFR-3-IN-1			VEGFR3, IC₅₀: 110.4 nM	98.55%
JI-101		VEGFR2		99.78%
VEGFR-2-IN-39		VEGFR2		99.85%
ENMD-2076 Tartrate		KDR, IC₅₀: 58.2 nM	Flt-4, IC₅₀: 15.9 nM	99.42%
KRN-633	VEGFR1, IC₅₀: 170 nM	VEGFR2, IC₅₀: 160 nM	VEGFR3, IC₅₀: 125 nM	99.45%
WHI-P180		KDR, IC₅₀: 66 nM		99.62%
Chloropyramine hydrochloride			VEGFR-3	99.73%
EOC317		VEGFR2, IC₅₀: 2 nM		98.05%
TG 100801	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 7 nM		98.61%
GSK2646264		VEGFR2, pIC₅₀: 4.5		98.39%
Motesanib Diphosphate	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 3 nM	VEGFR3, IC₅₀: 6 nM	99.64%
NVP-BAW2881	VEGFR1, IC₅₀: 820 nM	VEGFR2, IC₅₀: 9 nM	VEGFR3, IC₅₀: 420 nM	98.54%
SU4312		Flk-1		99.76%
GW297361		VEGFR2, IC₅₀: 120 nM		98.13%
Dovitinib lactate	VEGFR1, IC₅₀: 1 nM	VEGFR2, IC₅₀: 13 nM	VEGFR3, IC₅₀: 8 nM	99.75%
Vatalanib		VEGFR2, IC₅₀: 37 nM		99.93%
AAL993	VEGFR1, IC₅₀: 130 nM	VEGFR2, IC₅₀: 23 nM	VEGFR3, IC₅₀: 18 nM	99.50%
VEGFR2-IN-2		VEGFR2, IC₅₀: 19.32 nM		99.64%
XL 999	Flt-1, IC₅₀: 4 nM	KDR, IC₅₀: 20 nM		99.34%
EVT801	VEGFR1, IC₅₀: 396 nM	VEGFR2, IC₅₀: 130 nM	VEGFR3, IC₅₀: 11 nM
R1530		KDR, IC₅₀: 10 nM		99.06%
Hypothemycin	VEGFR1, Ki: 70 nM	VEGFR2, Ki: 10 nM		≥98.0%
TIE-2/VEGFR-2 kinase-IN-2		VEGFR-2		99.79%
DMH4		VEGFR2, IC₅₀: 0.16 μM		98.98%
AZD2932		VEGFR2, IC₅₀: 8 nM		99.04%
(Z)-Orantinib		Flk-1/KDR, IC₅₀: 2.1 μM		99.44%
Acrizanib		VEGFR-2, IC₅₀: 17.4 nM		99.84%
GW768505A free base		KDR (^[1])		98.66%
JK-P3		VEGFR2, IC₅₀: 7.83 μM		99.72%
Ponatinib-d₈		VEGFR2, IC₅₀: 1.5 nM		99.91%
ZM 306416	Flt-1, IC₅₀: 2 μM	KDR, IC₅₀: 100 nM		99.80%
ZD-4190		VEGFR2		98.08%
Ilorasertib	VEGFR1, IC₅₀: 1 nM	VEGFR2, IC₅₀: 2 nM	VEGFR3, IC₅₀: 43 nM	99.86%
Telatinib mesylate		VEGFR2, IC₅₀: 6 nM	VEGFR3, IC₅₀: 4 nM	99.74%
Ningetinib Tosylate		VEGFR2, IC₅₀: 1.9 nM		99.59%
SU5205		Flk-1, IC₅₀: 9.6 μM		98.02%
SU5204		VEGFR2, IC₅₀: 4 μM		99.46%
SU5214		Flk-1, IC₅₀: 14.8 μM		≥98.0%
Tyrphostin AG1433		Flk-1, IC₅₀: 9.3 μM		99.08%
NVP-ACC789	VEGFR-1, IC₅₀: 0.38 μM	VEGFR-2, IC₅₀: 0.02 μM mVEGFR-2, IC₅₀: 0.23 μM	VEGFR-3, IC₅₀: 0.18 μM	99.52%
VEGFR-2-IN-29		VEGFR-2, IC₅₀: 16.5 nM		99.71%
VEGFR-2-IN-5		VEGFR2
CP-547632 TFA		VEGFR2, IC₅₀: 11 nM		99.42%
JNJ-38158471		VEGFR-2, IC₅₀: 40 nM
Sunitinib-d₁₀		VEGFR2, IC₅₀: 80 nM		99.89%
Vandetanib hydrochloride		VEGFR2, IC₅₀: 40 nM	VEGFR3, IC₅₀: 110 nM
TG 100572	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 7 nM
Pamufetinib		VEGFR2, IC₅₀: 30 nM		98.28%
Sitravatinib malate	VEGFR1, IC₅₀: 6 nM	VEGFR2, IC₅₀: 5 nM	VEGFR3, IC₅₀: 2 nM
Dovitinib lactate hydrate	VEGFR1, IC₅₀: 1 nM	VEGFR2, IC₅₀: 13 nM	VEGFR3, IC₅₀: 8 nM
Cabozantinib hydrochloride	Flt-1, IC₅₀: 12 nM	VEGFR2, IC₅₀: 0.035 ± 0. nM	Flt-4, IC₅₀: 6 nM
Regorafenib mesylate	VEGFR1, IC₅₀: 13 ± 0.4 nM	VEGFR2, IC₅₀: 4.2 ± 1.6 nM	VEGFR3, IC₅₀: 46 ± 10 nM
Tivozanib hydrate	VEGFR1, IC₅₀: 30 nM	VEGFR2, IC₅₀: 6.5 nM	VEGFR3, IC₅₀: 15 nM	≥99.0%
Famitinib malate		VEGFR2, IC₅₀: 4.2 nM
Pulocimab		VEGFR2
SU 5402 (GMP)		VEGFR2, IC₅₀: 20 nM
VEGFR-2-IN-21		VEGFR-2, IC₅₀: 0.10 μM
CLM3		VEGFR2
Multi-kinase inhibitor 3	VEGFR1, IC₅₀: 1.59 nM	VEGFR2, IC₅₀: 1.23 nM	VEGFR3, IC₅₀: 1.19 nM
Apoptotic agent-4		VEGFR2, IC₅₀: 0.5717 μM
Multi-kinase-IN-4		VEGFR2, IC₅₀: 0.33 μM
VEGFR-2-IN-15		VEGFR2
VEGFR-2/STAT-3-IN-1		VEGFR2, IC₅₀: 26.3 nM
VEGFR-2/BRAF-IN-2		VEGFR2, IC₅₀: 0.111 μM
VEGFR-2-IN-18		VEGFR2, IC₅₀: 60 nM
Vatalanib succinate	Flt-1, IC₅₀: 77 nM	KDR, IC₅₀: 37 nM	Flt-4, IC₅₀: 730 nM
VEGFR-2-IN-30		VEGFR2, IC₅₀: 66 nM
FGFR3-IN-2		VEGFR2, IC₅₀: 570 nM
VEGFR-2-IN-43		VEGFR2, IC₅₀: 39.91 μM
(Rac)-SAR131675			VEGFR3
VEGFR-2-IN-17		VEGFR2, IC₅₀: 67.25 nM
TIE-2/VEGFR-2 kinase-IN-5		VEGFR-2, IC₅₀: 8.11 nM
VEGFR-2/BRAF-IN-1		VEGFR2, IC₅₀: 0.049 μM
VEGFR-2-IN-23		VEGFR-2, IC₅₀: 0.19 nM
HDAC-IN-35		VEGFR2, IC₅₀: 13.2 μM
hCA/VEGFR-2-IN-5		VEGFR-2, IC₅₀: 0.38 μM
Coibamide A		VEGFR2
SA-VA		VEGFR-2
VEGFR-2-IN-19		VEGFR2
hVEGF-IN-2	VEGFR1, IC₅₀: 2.5 μM
VEGFR-2-IN-27		VEGFR-2, IC₅₀: 14.8 nM
EGFR-IN-116		VEGFR-2, IC₅₀: 0.069 μM
Rhamnazin		VEGFR2, IC₅₀: 4.68 μM
YF-452		VEGFR2
YS07		VEGFR-2
VEGFR-2-IN-13		VEGFR2, IC₅₀: 3.4 nM
VEGFR-2/DHFR-IN-1		VEGFR-2, IC₅₀: 0.384 μM
T-1-MCPAB		VEGFR-2, IC₅₀: 0.135 μM
VEGFR-2-IN-28		VEGFR-2, IC₅₀: 0.83 μM
ML786 dihydrochloride		KDR, IC₅₀: 6.2 nM
VEGFR-2/DHFR-IN-2		VEGFR2, IC₅₀: 0.623 μM
VEGFR2-IN-3		VEGFR2
VEGFR-2-IN-53		VEGFR2, IC₅₀: 4.34 μM
VEGFR-2-IN-45		VEGFR-2, IC₅₀: 0.2 μM
PP487		VEGFR2, IC₅₀: 0.055 μM
Takeda-6D		VEGFR2, IC₅₀: 2.2 nM
T-1-MBHEPA		VEGFR-2, IC₅₀: 0.121 μM
HSP90-IN-13		VEGFR-2, IC₅₀: 126.95 nM
SA-PA		VEGFR-2
Vulinacimab		VEGFR-2
VEGFR2-IN-1		VEGFR2, IC₅₀: 19.8 nM
VEGFR-2-IN-41		VEGFR-2, IC₅₀: 0.0554 μM
3-Methylthienyl-carbonyl-JNJ-7706621		VEGFR2, IC₅₀: 0.13 μM
c-Met-IN-11		VEGFR-2, IC₅₀: 71.1 nM
VEGFR-2/AKT-IN-1		VEGFR2, IC₅₀: 0.164 μM
VEGFR-2/InhA-IN-1		VEGFR2, IC₅₀: 15.27 nM
VEGFR-2-IN-22		VEGFR2, IC₅₀: 19.82 nM
EGFR-IN-57		VEGFR-2, IC₅₀: 0.087 μM
(±)-Aiphanol		VEGFR2, IC₅₀: 0.92 μM
VEGFR-2-IN-55		VEGFR-2, IC₅₀: 1.24 nM
VEGFR-2-IN-40		VEGFR2
MET kinase-IN-3		VEGFR2, IC₅₀: 68 nM
CA IX/VEGFR-2-IN-2		VEGFR-2, IC₅₀: 32.1 nM
VEGFR-2/c-Met-IN-2		VEGFR-2, IC₅₀: 83 nM
VEGFR-2-IN-16		VEGFR2, IC₅₀: 86.36 nM
Multi-kinase-IN-2	VEGFR-1, IC₅₀: 31 ± 2.1 nM	VEGFR-2, IC₅₀: 6.5 ± 0.9 nM	VEGFR-3, IC₅₀: 6.3 ± 0.5 nM
TRK II-IN-1		VEGFR2, IC₅₀: 71.1 nM
SU5208		VEGFR2		99.48%
FGFR1/VEGFR2-IN-2		VEGFR2, IC₅₀: 0.025 μM
Multi-kinase-IN-3		VEGFR-2, IC₅₀: 58.3 ± 5.9 nM
VS 8		VEGFR-2
EGFR/VEGFR2-IN-1		VEGFR-2, IC₅₀: 0.26 μM
VEGFR-2-IN-14		VEGFR2
VEGFR-2-IN-47		VEGFR2, IC₅₀: 0.072 μM
VEGFR-2-IN-26		VEGFR-2, IC₅₀: 15.5 nM
TIE-2/VEGFR-2 kinase-IN-3		VEGFR-2, IC₅₀: 3.5 nM
Multi-kinase-IN-5	VEGFR1	VEGFR2
TIE-2/VEGFR-2 kinase-IN-4		VEGFR-2, IC₅₀: 5.1 nM
BMS-605541	VEGFR-1, IC₅₀: 400 nM	VEGFR-2, IC₅₀: 23 nM VEGFR-2, Ki: 49 nM Flk-1, IC₅₀: 40 nM		99.57%
VEGFR-2-IN-11		VEGFR-2, IC₅₀: 60.27 nM
VEGFR2/HDAC1-IN-1		VEGFR-2, IC₅₀: 57.83 nM
ZINC09875266		VEGFR-2
VEGFR-2-IN-25		VEGFR2, IC₅₀: 12.1 nM
VEGFR-IN-5		VEGFR2, IC₅₀: 8.4 nM
R916562		VEGF-R2, IC₅₀: 24 nM
PI3K/VEGFR2-IN-1		VEGFR2, IC₅₀: 68 μM
Henatinib		VEGFR-2, IC₅₀: 0.6 nM
VEGFR-2-IN-31		VEGFR2
VEGFR-2-IN-24		VEGFR2, IC₅₀: 0.22 μM
WHI-P180 hydrochloride		KDR, IC₅₀: 66 nM
SJ-C1044		VEGFR2, IC₅₀: 100 nM
ZM323881		VEGFR2, IC₅₀: 2 nM
TG 100801 Hydrochloride	VEGFR1, IC₅₀: 2 nM	VEGFR2, IC₅₀: 7 nM
SKLB646		VEGFR2, IC₅₀: 0.012 μM
VEGFR-2-IN-44		Flk-1, IC₅₀: 70 nM
ZM-306416 hydrochloride	Flt-1, IC₅₀: 2000 nM	KDR, IC₅₀: 100 nM
ZK-261991		VEGFR2, IC₅₀: 5 nM
Vandetanib trifluoroacetate		VEGFR2, IC₅₀: 40 nM	VEGFR3, IC₅₀: 110 nM
Lucitanib dihydrochloride	VEGFR1, IC₅₀: 7 nM	VEGFR2, IC₅₀: 25 nM	VEGFR3, IC₅₀: 10 nM
VEGFR-2-IN-12		VEGFR2, IC₅₀: 0.037 μM
VEGFR-2-IN-9		KDR, IC₅₀: 7 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.